Assessing Perceptions and Preferences around Long-acting Injectables
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Two-year retrospective exploring innovative approaches to reduce stigma and isolation among cis and transgender women of color with HIV, including women with HIV residing in rural areas not connected to care.
Resource (Conference Presentation) updated 09/14/2023
Attorneys from the Ryan White Legal Project at Indiana Legal Services, Inc. discuss how the medical legal partnership model enhances service delivery to RWHAP patients.
Resource (Conference Presentation) updated 09/14/2023
Review of how to address intersectional stigma to improve HIV care engagement and retention and approaches to stigma reduction for healthcare providers and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
This workshop presents providers and jurisdictions with tools and frameworks to measure stigma, assess implementation readiness and implement stigma reduction activities.
Resource (Conference Presentation) updated 09/14/2023
Boston Public Health Commission's Ryan White Planning Council shares its approach for creating and launching an HIV anti-stigma campaign inclusive of a video.
Resource (Conference Presentation) updated 09/14/2023
Launch of a website and social media campaign to create public health awareness around EHE and to destigmatize people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource updated 10/13/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource updated 09/19/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
We conducted semi-structured interviews with service providers to investigate current barriers, potential opportunities, estimated costs, and anticipated outcomes of program expansion for food, financial, transportation, and housing support services for RWHAP clients.
Resource (Conference Presentation) updated 09/14/2023
We used a data-driven, mixed method approach to develop a community planning and budget tool to inform resource allocation decision-making to achieve health equity in HIV outcomes among RWHAP clients in the Minneapolis-St. Paul Transitional Grant Area.
Resource (Conference Presentation) updated 09/14/2023
The COVID-19 public health emergency (PHE) exacerbated homelessness and housing instability. NY EMA Planning staff worked collaboratively to address homelessness as a driving force of poorer health outcomes for people living with HIV. This presentation will illustrate community planning processes for addressing housing-related barriers among RWHAP consumers during the PHE.
Resource (Conference Presentation) updated 09/14/2023